Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999-2008
- PMID: 22688539
- PMCID: PMC4521396
- DOI: 10.1007/s10995-012-1046-3
Prevalence of hospitalized live births affected by alcohol and drugs and parturient women diagnosed with substance abuse at liveborn delivery: United States, 1999-2008
Abstract
To describe prevalence trends in hospitalized live births affected by placental transmission of alcohol and drugs, as well as prevalence trends among parturient women hospitalized for liveborn delivery and diagnosed with substance abuse problems in the United States from 1999 to 2008. Comparison of the two sets of trends helps determine whether the observed changes in neonatal problems over time were caused by shifts in maternal substance abuse problems. This study independently identified hospitalized live births and maternal live born deliveries from discharge records in the Nationwide Inpatient Sample, one of the largest hospital administrative databases. Substance-related diagnosis codes on the records were used to identify live births affected by alcohol and drugs and parturient women with substance abuse problems. The analysis calculated prevalence differences and percentage changes over the 10 years, with Loess curves fitted to 10-year prevalence estimates to depict trend patterns. Linear and quadratic trends in prevalence were simultaneously tested using logistic regression analyses. The study also examined data on costs, primary expected payer, and length of hospital stays. From 1999 to 2008, prevalence increased for narcotic- and hallucinogen-affected live births and neonatal drug withdrawal syndrome but decreased for alcohol- and cocaine-affected live births. Maternal substance abuse at delivery showed similar trends, but prevalence of alcohol abuse remained relatively stable. Substance-affected live births required longer hospital stays and higher medical expenses, mostly billable to Medicaid. The findings highlight the urgent need for behavioral intervention and early treatment for substance-abusing pregnant women to reduce the number of substance-affected live births.
Figures
Similar articles
-
Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.Pharmacotherapy. 2017 Jul;37(7):806-813. doi: 10.1002/phar.1947. Epub 2017 Jun 21. Pharmacotherapy. 2017. PMID: 28500694
-
Association of Punitive and Reporting State Policies Related to Substance Use in Pregnancy With Rates of Neonatal Abstinence Syndrome.JAMA Netw Open. 2019 Nov 1;2(11):e1914078. doi: 10.1001/jamanetworkopen.2019.14078. JAMA Netw Open. 2019. PMID: 31722022 Free PMC article.
-
Neonatal drug withdrawal syndrome: cross-country comparison using hospital administrative data in England, the USA, Western Australia and Ontario, Canada.Arch Dis Child Fetal Neonatal Ed. 2016 Jan;101(1):F26-30. doi: 10.1136/archdischild-2015-308948. Epub 2015 Aug 19. Arch Dis Child Fetal Neonatal Ed. 2016. PMID: 26290479
-
Overview and epidemiology of substance abuse in pregnancy.Clin Obstet Gynecol. 2013 Mar;56(1):91-6. doi: 10.1097/GRF.0b013e31827feeb9. Clin Obstet Gynecol. 2013. PMID: 23314721 Review.
-
[Consequences of tobacco, cocaine and cannabis consumption during pregnancy on the pregnancy itself, on the newborn and on child development: A review].Encephale. 2015 Jun;41 Suppl 1:S13-20. doi: 10.1016/j.encep.2014.08.012. Epub 2014 Oct 28. Encephale. 2015. PMID: 25439854 Review. French.
Cited by
-
Healthcare professionals' and budtenders' perceptions of perinatal cannabis use.Am J Drug Alcohol Abuse. 2022 Mar 4;48(2):186-194. doi: 10.1080/00952990.2021.1988091. Epub 2021 Nov 15. Am J Drug Alcohol Abuse. 2022. PMID: 34779673 Free PMC article.
-
Improving translational relevance: The need for combined exposure models for studying prenatal adversity.Brain Behav Immun Health. 2021 Jul 6;16:100294. doi: 10.1016/j.bbih.2021.100294. eCollection 2021 Oct. Brain Behav Immun Health. 2021. PMID: 34589787 Free PMC article.
-
Methadone for Opioid Use Treatment during Pregnancy: Trends in Postpartum Dose Adjustments.AJP Rep. 2020 Jul;10(3):e202-e209. doi: 10.1055/s-0040-1713787. Epub 2020 Aug 4. AJP Rep. 2020. PMID: 33094005 Free PMC article.
-
Daily Cannabis Use During Pregnancy and Postpartum in a State With Legalized Recreational Cannabis.J Addict Med. 2020 Dec;14(6):467-474. doi: 10.1097/ADM.0000000000000625. J Addict Med. 2020. PMID: 32011411 Free PMC article.
-
Alcohol use and binge drinking among U.S. men, pregnant and non-pregnant women ages 18-44: 2002-2017.Drug Alcohol Depend. 2019 Dec 1;205:107590. doi: 10.1016/j.drugalcdep.2019.107590. Epub 2019 Sep 27. Drug Alcohol Depend. 2019. PMID: 31600616 Free PMC article.
References
-
- Susbstance Abuse and Mental Health Services Administration (SAMSHA) Results from the 2008 National Survey on Drug Use and Health: National findings. SAMSHA, Office of Applied Studies; Rockville, MD: 2009. (NSDUH Series H-36). HHS Publication No. SMA 09-4434.
-
- Bertrand J, Floyd RL, Weber MK, O'Connor M, Riley EP, Johnson KA, Cohen DE, National Task Force on FAS/FAE . Fetal Alcohol Syndrome: Guidelines for referral and diagnosis. Centers for Disease Control and Prevention; Atlanta, GA: 2004.
-
- Addis A, Moretti ME, Ahmed Syed F, Einarson TR, Koren G. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol. 2001;15(4):341–369. - PubMed
-
- Gouin K, Murphy K, Shah PS. Effects of cocaine use during pregnancy on low birthweight and preterm birth: systematic review and metaanalyses. Am J Obstet Gynecol. 2011;204:340.e1–e12. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
